Breast Cancer: Biomarkers and Clinical Management
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Disease Biomarker".
Deadline for manuscript submissions: 20 November 2024 | Viewed by 1326
Special Issue Editors
Interests: breast radiology; mammography; breast ultrasound; breast MRI; oncological radiology; abdominal and pelvic ultrasound (US) and US Doppler; osteo-articular ultrasound; endocavitary ultrasound; Computed Tomography (CT); CT angiography, including cardio-vascular imaging
Interests: breast cancer; triple negative breast cancer; HER2 positive; immunotherapy; targeted therapy; gynecological cancer
Special Issue Information
Dear Colleagues,
In reference to global epidemiological data, which indicate an increasing incidence of breast cancer, especially in younger female population groups, and the concomitant technological advancement in early detection (radiological imaging, pathological anatomy, and genetics, for example), in order to anticipate tumor detection, in very dense and young breasts, we are pleased to invite the scientific community and experts in this field to present their innovative research and studies in the following areas:
- Imaging: CEM (contrast enhancement mammography)
- Imaging: MRI (screening and ultrafast MRI and DWI) in young women
- New protocols and guidelines
- The application of AI algorithms for detection and biopsy guidance
- Advanced genetic screening techniques
- Clinical and genetic biomarkers
- Genomics and radiomics for the identification of therapeutic targets
- Analysis of the correlation between tumor occurrence and gut bacterial flora patterns
- Advances in anatomic pathology
- Personalized medicine for the treatment of breast cancer
- Advances in therapeutic lines (in situ Ca,B3)
- New surgical approaches
- New non-surgical approaches (cryoablation techniques, for example)
- New radiotherapy approaches
- New medical therapy approaches (chemotherapy and immunotherapy)
We welcome the cooperation of all researchers dedicated to advancing the field in question.
Dr. Pierluigi Maria Rinaldi
Dr. Antonella Lai
Guest Editors
Dr. Rino Aldo Montella
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- triple-negative breast cancer
- targeted therapy
- inhibitors
- breast cancer biomarkers
- immune therapy
- personalized medicine
- mammography with contrast medium
- magnetic resonance imaging
- artificial intelligence
